Regeneron Healthcare Solutions, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$118Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
99,393clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $15M
2020 $5.6M
2021 $9.0M
2022 $15M
2023 $21M
2024 $24M
2025 $28M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Dermatology $27M
Allergy & Immunology $11M
Ophthalmology $9.6M
Pulmonary Disease $7.9M
Retina Specialist $7.8M
Hematology & Oncology $6.9M

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Alexandra Golant New York, NY Dermatology $820,643.64
Ehsan Rahimy Stanford, CA Retina Specialist $818,683.04
Seenu Hariprasad Chicago, IL Ophthalmology $739,710.97
Dilsher Dhoot Santa Barbara, CA Retina Specialist $719,807.10
Gregory Bensch Stockton, CA $712,506.35
Marcjonathan Serota Littleton, CO Dermatology $711,483.06
Matthew Zirwas Bexley, OH Dermatology $703,986.07
Elizabeth Swanson Meridian, ID Pediatric Dermatology $647,707.92
Martin Dietrich Rockledge, FL Hematology & Oncology $636,482.12
Jonathan Silverberg Washington, DC Dermatology $608,571.74

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.